Budesonide Tablet, Film Coated, Extended Release
Product Images NDC 0591-2510

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 0591-2510). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula For Budesonide (Image 1)

Chemical structure diagram of budesonide, showing its molecular framework with various rings, hydroxyl groups, and a side chain, consistent with the corticosteroid class.*

FDA Label Image

Ndc 0591-2510-30 (Image 2)

Budesonide 9 mg Extended-Release Tablets label for oral use. The film-coated tablets are intended to be swallowed whole without chewing, crushing, or breaking. Packaging shows 30 tablets, manufactured by Actavis Laboratories FL, Inc., and distributed by Actavis Pharma, Inc. Includes storage instructions and a barcode on the right side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.